This is a retrospective case series of 42 arthroscopic ECRB releases for recalcitrant lateral epicondylitis. It introduces a three-type arthroscopic classification based on capsular integrity and reports minimum 2-year clinical outcomes. The study asks whether arthroscopic release is reliable and whether lesion type predicts results.
When a patient has failed 6-12 months of conservative care for tennis elbow, arthroscopic ECRB release is a reasonable surgical option with 95% good outcomes and a fast return to work.
The key teaching point is counterintuitive: the arthroscopic capsular appearance you use to classify the lesion does not predict how the patient will do. The pathology is degenerative tendinosis of the ECRB, so you address the tendon regardless of what the capsule looks like.
Remember that tennis elbow is angiofibroblastic tendinosis, not inflammation. This is why NSAIDs and repeated steroid injections have limited durable benefit and why surgery targets debridement of degenerative tendon. Counsel workers' compensation patients realistically. They report more pain postoperatively even when function recovers, a pattern seen across the tennis elbow literature.
Arthroscopy also lets you diagnose and treat intraarticular pathology (synovitis, loose bodies, spurs) found in roughly two-thirds of these elbows without a second incision.
This is a retrospective case series of 42 arthroscopic ECRB releases for recalcitrant lateral epicondylitis. It introduces a three-type arthroscopic classification based on capsular integrity and reports minimum 2-year clinical outcomes. The study asks whether arthroscopic release is reliable and whether lesion type predicts results.
When a patient has failed 6-12 months of conservative care for tennis elbow, arthroscopic ECRB release is a reasonable surgical option with 95% good outcomes and a fast return to work.
The key teaching point is counterintuitive: the arthroscopic capsular appearance you use to classify the lesion does not predict how the patient will do. The pathology is degenerative tendinosis of the ECRB, so you address the tendon regardless of what the capsule looks like.
Remember that tennis elbow is angiofibroblastic tendinosis, not inflammation. This is why NSAIDs and repeated steroid injections have limited durable benefit and why surgery targets debridement of degenerative tendon. Counsel workers' compensation patients realistically. They report more pain postoperatively even when function recovers, a pattern seen across the tennis elbow literature.
Arthroscopy also lets you diagnose and treat intraarticular pathology (synovitis, loose bodies, spurs) found in roughly two-thirds of these elbows without a second incision.